NCT01158898 - Efficacy of TPI ASM8 During a 14-Day Allergen Challenge | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

February 29, 2012

Conditions

Asthma

Interventions

DRUG

TPI ASM8

ASM8 4mg/mL (low dose) daily for 14 days by inhalation

DRUG

TPI ASM8

ASM8 4mg/mL (high dose) daily for 14 days by inhalation

DRUG

TPI ASM8

Placebo PBS solution daily for 14 days by inhalation

Trial Locations (4)

Health Research Innovation Centre, Calgary

Vancouver Coastal Health Research Institute, Vancouver

McMaster University, Hamilton

Laval Centre de Pneumologie Chest Division, Québec